Flexiti Financial Inc. (“Flexiti”), a leading provider of buy now, pay later point-of-sale consumer financing solutions for retailers, announced today it has launched its 0% interest¹ financing solution at London Drugs. This launch follows a successful pilot program in select London Drugs locations that launched earlier this year.

Through Flexiti’s omni-channel solution, customers can apply for a FlexitiCard^® in-store at 78 London Drugs locations. The paperless application takes minutes to complete, and upon approval, the FlexitiCard can immediately be used to make purchases. This fully automated and 100% paperless process offers qualified customers a revolving credit line and flexible payment plans with 0% interest¹ financing options, eliminating the need to reapply for financing for future purchases.

With Flexiti’s financing, London Drugs customers can get access to 0% interest¹ financing to purchase a variety of products. London Drugs’ diverse products range from TVs, computers and gaming to the unexpected, like ebikes and paddle boards. They offer a Connected Health and Wellness selection of products for smart fitness, home safety and more.

“For more than 75 years, London Drugs has been elevating the pharmacy experience, becoming an integral part of the lives of western Canadians,” says Clint Mahlman, London Drugs, President and COO. “It’s never been more important to provide Canadians with affordable payment solutions which is why we are excited to partner with Flexiti to introduce 0% interest financing plans for our customers. We look forward to working with Flexiti as we continue to push the boundaries of what traditional pharmacies look like.”

“Flexiti is always looking for innovative ways to add value to our growing network of over 7,000 retail locations,” says Peter Kalen, Founder and CEO of Flexiti. “With 78 retail locations across Western Canada, we are thrilled to be adding London Drugs to our network. This partnership means there are now even more locations for our cardholders to shop exceptional products with access to flexible financing solutions that will help make their purchases and lives more affordable.”

¹ O.A.C. Terms and conditions apply.

About Flexiti

Founded in 2013 by Peter Kalen, Flexiti is one of Canada's fastest-growing buy now, pay later point-of-sale lenders, offering customers 0% interest financing at retailers that sell big-ticket goods like furniture, appliances, jewellery and electronics. Through its award-winning omni-channel platform, customers can be approved instantly to shop with their FlexitiCard^®, which they can use online or in-store to make multiple purchases, within their credit limit, without needing to reapply. Accepted at over 7,000 locations and ecommerce sites across Canada including The Brick, Leon's, Staples, Sleep Country, Wayfair, Birks and Peoples Jewellers, Flexiti aims to make our customers' lives more affordable and help our retail partners grow their sales by offering flexible financing options.

Flexiti's growth, driven by its financing platform, is recognized as market leading. In 2019, Flexiti was named Canada's 11th fastest growing company by the Globe and Mail, ranked 7th in the Deloitte Technology Fast 50^TM program, and 40th in Deloitte North America Technology Fast 500^TM. In 2020, Flexiti ranked 29th in The Americas' 500 Fastest Growing Companies by the Financial Times, 6th in The Globe and Mail’s Canada’s Top Growing Companies, 3rd on the 2020 Growth List and 6th and 39th on Deloitte Technology Fast 50^TM and Fast 500^TM, respectively. In 2021, Flexiti ranked 13^th on The Globe and Mail’s Canada’s Top Growing Companies. Flexiti is a wholly-owned subsidiary of CURO Group Holdings Corp. (NYSE: CURO).

For more information, visit www.flexiti.com.

About London Drugs

Founded in 1945, B.C.-based London Drugs sells to every province and territory in Canada through its online store www.LondonDrugs.com and has 79 physical stores in more than 35 major markets throughout British Columbia, Alberta, Saskatchewan and Manitoba. London Drugs offers consumers a range of products from personal protection equipment for pandemic safety, to digital cameras and cosmetics to computers and televisions. Renowned for its creative approach to retailing, the company employs more than 9000 people with pharmacy and health care services being the heart of its business. Committed to innovation and superior customer service, London Drugs has established itself as a reputable and caring Canadian company that supports Canadian brands and continues to position itself for future growth and development.

(CURO-NWS)

Source: CURO Group Holdings Corp.; Flexiti

View source version on businesswire.com: https://www.businesswire.com/news/home/20210928005183/en/